As Philips stares down an international recall of more than 2 million of its CPAP and sleep apnea machines, the respiratory devicemaker ResMed is looking to pick up the slack—but the surge in demand ...

As Philips continues to work through its massive recall initiated 15 months ago impacting ventilators and sleep apnea devices, ResMed continues working to keep up with excess demand for CPAP ...

The last 12 months have been nothing short of a whirlwind for ResMed. After finding itself scrambling to pick up the slack left in the wake of Philips’ massive respiratory device recall last June, it ...

Shares of ResMed RMD rose 6% to reach $231.70 after the company’s peer in the field of sleep apnea devices, Koninklijke Philips PHG issued recall notification for a series of its sleep and respiratory ...

When do medical device companies sound like parents proudly touting how their toddlers eat vegetables? When they can demonstrate that thousands of patients are adhering to a difficult therapy using ...

Mizuho said Wednesday that ResMed (NYSE:RMD) is now positioned to retain the more than $450M in US market share gains for "much longer" than anticipated, thanks to Philips’ (NYSE:PHG) recently ...

The Philips respiratory machine recall is a no-win situation for patients and doctors. But for the medical device giant’s longtime rivals and new competitors, business is looking up. “We think it will ...

Philips Respironics and ResMed have teamed up to introduce the new CPAP machine, a product for people who are unaware that their insomnia and sleepless nights may be a result of insufficient airflow.

Philips yesterday noted that its recall notification was to voluntarily withdraw specific Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP) and ...